SlideShare a Scribd company logo
SCREENING METHODS
OF ANTIDIABETIC
DRUGS
PRESENTED BY:
SHUBHA SHARMA
M.SC. PHARMACOLOGY
RUHS-CMS, JAIPUR
INTRODUCTION
 The pancreas is an organ composed of exocrine and endocrine cells.
 Islets of langerhans, which forms the endocrine part , consist of four types of
cells alpha, beta, delta and PP cells.
 Glucose stimulates the beta cells to release insulin, which then promotes glucose
uptake and storage.
 “Diabetes mellitus is characterized by derangement in carbohydrate, protein and
fat metabolism caused by the complete or relative insufficiency of insulin
secretions and/ or insulin action.”
TYPES OF DIABETES
There are 2 major types of diabetes:
1) Type 1 Diabetes (associated with insulin deficiency)
 Also called as Insulin-dependant diabetes mellitus (IDDM)/ juvenile onset
 Type 1 diabetes is believed to be an autoimmune condition. It happens when
immune system mistakenly attacks and destroys the beta cells in your pancreas
that produce insulin. The damage is permanent.
2) Type 2 Diabetes (associated with insulin resistance)
 Also called as Non Insulin-dependant Diabetes mellitus (NIDDM)
 Most common form of diabetes. Usually occurs in adulthood but diagnosis is
in the younger generation.
 The exact cause is unknown. Contributing factors may include genetics, obesity,
hyperinsulinemia and insulin resistance.
 Insulin resistance may be due to the defect at receptor level or at the postreceptor
level.
 This means your body can’t use insulin efficiently.
SCREENING OF ANTIDIABETIC
DRUGS
MODELS FOR IDDM (TYPE I)
1. Chemically induced diabetes
 Alloxan
 Streptozotocin
2. Hormones induced diabetes
3. Virus induced diabetes
4. Insulin antibodies- induced diabetes
5. Surgically induced diabetes
MODELS FOR NIDDM (TYPE II)
1. Chemically induce d Diabetes
i. Neonatal STZ model for NIDDM
2. Genetic models
I. Monogenic model for NIDDM
a) Yellow Mouse (The Agouty Mouse)
b) Obese and Diabetic Mouse
II. Polygenic model for NIDDM
a) New Zealand Obese mouse (NZO)
b) Japanies KK Mouse
CHEMICALLY INDUCED DIABETES
1. Alloxan induced Diabetes:
 Alloxan have capacity to produce reversible diabetes.
 It is a toxic cyclic urea analogue which destroys β-cells of the islets of Langerhans in pancreas.
 This compound causes severe necrosis of pancreatic β-cells .
 It has been suggested that allloxan induces the production of H 2O2 and some free radicals
such as O2 and OH- that produce first damage and later the death of β-cells.
Mechanism
Alloxan has two distinct pathological effects:
 Alloxan is highly reactive
molecule that is readily reduced
to dialuric acid,
Dialuric acid is then auto-oxidized
back to alloxan resulting in the
production of free radicals.
These free radicals damage the DNA
of β -cells and cause cell death.
 Its ability to react with protein SH
groups, especially the membrane
proteins like Glucokinase on the
β - cells, finally resulting in the
cell necrosis..
Procedure
 Animals: Rats of Wistar or Sprague–Dawley strain(150-200 g)
 Inducing agent: Alloxan (100-175 mg/kg s.c.)
 Maintain rats at standard environment and laboratory chow.
 All the animals , which are given alloxan, receive glucose and insulin
for one week and food ad libitum.
 Thereafter, single daily dose of 28 IU insulin is administered s.c.
 The blood glucose level shows triphasic change, first a rise at 2Hr,
followed by hypoglycemic phase at 8Hr, finally an increase at
24Hr probably due to depletion of β -cells of insulin.
Evaluation:
 Any suitable method for estimation of
 Glucose level
 Insulin level
 Hepatic glycogen level
 Compare results of standard with control group animals.
Drawbacks
 High mortality in Rats
 Causes ketosis in animals due to free fatty acid generation
 Diabetes induced is reversible
 Some species like guinea pigs are resistant to its diabetogenic
action
Alloxan has been almost completely replaced by streptozotocin(STZ)
because of these drawbacks
2. Streptozotocin-induced Diabetes
 STZ [2- deoxy-2-(3-methyl-3-nitrosourea)1-D-glucopyranose]
 It is a broad-spectrum antibiotic, which is produced from
Streptomyces achromogens.
 It is used to induce both type 1 diabetes and type 2 diabetes at
dose of
1. Rat: 50-60 mg/kg i.p
2. Mice: 175-200mg/kg i.p or i.v
3. Dogs: 15mg/kg for 3 days
 Mechanism of causing B-
cell damage
a) By process of methylation
b) Free radical generation and
c) Nitric oxide production
Procedure
 STZ induces diabetes in almost all species of animals. Diabetic dose
varies with species and the optimal doses required in various
species are:
a) Rats(50-60mg/kg, i.p. or i.v.)
b) Mice(175-200mg/kg, i.p. or i.v.)
c) Dogs(15 mg/kg for 3 days)
 The blood glucose level shows the same triphasic response as seen
in the alloxan treated animals, with hyperglycemia at 1Hr,followed
by hypoglycemia which lasts for 6 Hr, and stable hyperglycemia
by 24-48Hr after STZ administration.
Advantages
 It has completely replaced Alloxan for inducing diabetes because of
:
1. Greater selectivity towards B-cells
2. Lower mortality rate
3. Irreversible diabetes induction
MODIFICATIONS
 Multiple low dose of STZ also induces diabetes by causing immune
mediated pancreatic insulitis in rats.
 Cyclosporin-A when given with STZ enhances its diabetogenic
efficacy.
 STZ combined with complete Freund’s adjuvant, administered 24h
prior to STZ (25mg/kg)and then repeated in the three subsequent
weeks, all produces hyperglycemia.
 Neither four administration of CFA nor of STZ alone result in
persistent hyperglycemia.
Hormones Induced Diabetes
 Animal: Rats, Guinea pigs and Rabbits
 Inducing hormone: Dexamethasone.
 Eg. NIDDM form of diabetes is induced when dexamethasone,a long-
acting glucocorticoid is administered at a dose of 2-5mg/kg i.p. twice a
day in rats
 In other animal models(like guinea pigs and rabbits), corticotrophin is
used to stimulate adrenal cortex that results in hormonal imbalance
causing steroidal diabetes.
VIRUS INDUCED DIABETES
 Principle: -
various human viruses used for inducing diabetes include
 RNA picorno virus
 encephalomyocarditis [EMC-D]
 coxsackie B4 [CB-4].
 Renovirus
 Mengo-2t
PROCEDURE
 6-8 week old mice are inoculated by 0.1 ml of 1:50 dilutions of D- variant
encephalomyocarditis [EMC] through i.p.
 0.1ml of above dilution contains 50 PFU [ plaque forming units] of EMC virus.
(mortality due to this concentration of virus is approximately 10-20%)
 A less infecting variant produces a comparable damage by eliciting
autoimmune reactivity to the beta cells.
 Infected animals are considered hyperglycaemic if there non fasting levels
exceed by 250mg/dl
 Drug samples to be screened are administered orally for a period of 6 weeks.
 After 6 weeks of drug treatment, blood glucose estimation is done to
determine the anti diabetic activity.
Insuline Antibodies-induced Diabetes
 Giving Bovine insulin along with CFA to guinea pigs produces anti-
insulin antibodies.
 Large doses and prolonged administration are accompanied by
ketonemia, ketonuria, glycosuria and acidosis are fatal to animals
 Lower doses produce reversible type of diabetes after a few hours.
Surgically -induced Diabetes
 Surgical removal of all or a part of pancreas.
 Total removal of pancreas result in the insulin dependant type of diabetes.
 Experimental animals are required to maintain isulin therapy.
 Pancreatectomy with chemical agents can produce a stable form of diabetes
in animlas such as cats and dogs.
 The combination therapy reduces the organ damage associated with chemical
induction and minimizes the interventions.
Genetically diabetic animals
The NOD Mouse
 Non Obese Diabetic Mouse
 These are the inbred strain of albino mice developed by Makino and
coworkers in Japan.
 Autoimmune destruction of β-cell in association with Insulitis and auto-
antibody production.
 Develop diabetes abruptly at the 100-200 days of age.
 Insulin treatment required for survival.
Genetically diabetic animals ….
WBN/ KOB rat:
 InbreedWistarstrain.
 Decrease in number and size of islets at 12 weeks of age.
 Aged male Wistar strain shows diabetic symptoms.
 Impairedglucosetoleranceandglycosuriaat21week of age.
MODELS FOR NIDDM
1. NEONATAL STZ MODEL
Streptozotocin causes severe pancreatic beta cells destruction,
accompanied by decrease in pancreatic insulin stores and rise in plasma
insulin levels.
Procedure: -
• Neonatal rats of Sprague-Dawley strain are taken
• Treated with STZ 80-100 mg/kg IP at birth or within 5 days of birth which leads
to severe β cell destruction, deficiency in pancreatic insulin levels and rise in
plasma glucose.
• In contrast to adults, the β cells in neonates partially regenerate.
• Following an initial spike in plasma glucose, these rats become normoglycemic
by 3 weeks.
Other chemical methods
• For NIDDM in rabbits - adrenaline (0.1 mg/kg SC).
• The hyperglycemia is seen at 1 hour and lasts for 4 hours. Oral
hypoglycemic agents can be screened by this method.
• Other chemicals are 8-hydroxy quinoline, biphenyl thio carbazine, EDTA
(partially depancreatized rats), thiazides, chlorthiazide, hydrochlorthiazide,
diazoxide and furosemide.
Genetic models for NIDDM
 Monogenic models of obesity and
NIDDM
1. Yellow mouse (the Agouti
mouse)
2.Obese and diabetic mouse
3.Tubby mouse
4.Fat mouse
5.Zucker diabetic fatty rat
6.Koletsky and JCR: LA-Corpulent
rats
 Polygenic models of obesity and
NIDDM
1. New Zealand obese mouse
2. Japanese KK mouse
3. Nagoya – Shibata – Yasuda mouse
4. PBB/Ld mouse
5. Goto-Kakisaki rat
6. Chinese Hamster
7. South African Hamster
THANKS…

More Related Content

What's hot

Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
Anupam dubey
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
Dr. Mallappa Shalavadi
 
Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3pharmacologyseminars
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
Shubham Kolge
 
Screening Methods for behavioural and muscle Coordination
 Screening Methods for behavioural and muscle Coordination Screening Methods for behavioural and muscle Coordination
Screening Methods for behavioural and muscle Coordination
pradnya Jagtap
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
Dr. Manu Kumar Shetty
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugs
Dr Roohana Hasan
 
Diuretics screening models
Diuretics screening modelsDiuretics screening models
Diuretics screening models
Jaineel Dharod
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
Rashmi116
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
Abin Joy
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
Prajitha p
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
drarunsingh4
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
S.G.S.S. COLLEGE OF PHARMACY, MANUR
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SreyaRathnaj
 
Screening of Dyslipidemic drugs
Screening of Dyslipidemic drugsScreening of Dyslipidemic drugs
Screening of Dyslipidemic drugs
Pavana K A
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
Uttara Joshi
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
Dr Roohana Hasan
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
Sravani Ganti
 
Pre clinical screening models for drugs acting on Autonomic nervous system
Pre clinical screening models for drugs acting on Autonomic nervous systemPre clinical screening models for drugs acting on Autonomic nervous system
Pre clinical screening models for drugs acting on Autonomic nervous system
Rana Rana
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
nazuk sharma
 

What's hot (20)

Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
 
Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
 
Screening Methods for behavioural and muscle Coordination
 Screening Methods for behavioural and muscle Coordination Screening Methods for behavioural and muscle Coordination
Screening Methods for behavioural and muscle Coordination
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugs
 
Diuretics screening models
Diuretics screening modelsDiuretics screening models
Diuretics screening models
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
 
Screening of Dyslipidemic drugs
Screening of Dyslipidemic drugsScreening of Dyslipidemic drugs
Screening of Dyslipidemic drugs
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Pre clinical screening models for drugs acting on Autonomic nervous system
Pre clinical screening models for drugs acting on Autonomic nervous systemPre clinical screening models for drugs acting on Autonomic nervous system
Pre clinical screening models for drugs acting on Autonomic nervous system
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
 

Similar to Antidiabetic screening

PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF  ANTIDIABETICS.pptxPRECLINICAL SCREENING OF  ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
VincyDinakaran
 
Diabetes screening
Diabetes screeningDiabetes screening
Diabetes screening
Kajal Rajdev
 
Preclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsPreclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugs
Abu Sufiyan Chhipa
 
Experimental evaluation of anti-diabetics
Experimental evaluation of anti-diabeticsExperimental evaluation of anti-diabetics
Experimental evaluation of anti-diabetics
Kirtan Bhatt
 
Models for screening of antidiabetic agents
Models for screening of antidiabetic agentsModels for screening of antidiabetic agents
Models for screening of antidiabetic agents
Tabindah Hesam
 
Methods for screening of hypoglycemics
Methods for screening of hypoglycemicsMethods for screening of hypoglycemics
Methods for screening of hypoglycemics
SSR COLLEGE OF PHARMACY
 
methodsforscreeningofhypoglycemics-180928062900 (1).pdf
methodsforscreeningofhypoglycemics-180928062900 (1).pdfmethodsforscreeningofhypoglycemics-180928062900 (1).pdf
methodsforscreeningofhypoglycemics-180928062900 (1).pdf
Sri Lakshmi
 
Em antidiabetic drugs
Em antidiabetic drugsEm antidiabetic drugs
Em antidiabetic drugs
Viraj Shinde
 
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGSANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
GOPALASATHEESKUMAR K
 
preclinical screening methods for Antidiabetic drugs
 preclinical screening methods for Antidiabetic drugs preclinical screening methods for Antidiabetic drugs
preclinical screening methods for Antidiabetic drugs
SachinGulia12
 
Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.
Nisar Ali
 
Diabetes mellitus (DM) ...
  Diabetes  mellitus (DM)                                                    ...  Diabetes  mellitus (DM)                                                    ...
Diabetes mellitus (DM) ...
ROBIN KAUR
 
diabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptxdiabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptx
jerriecesar
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
Kundlik Rathod
 
Screening model of antidiabetic drugs
Screening model of antidiabetic drugsScreening model of antidiabetic drugs
Screening model of antidiabetic drugs
Tanyasingh536250
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
Manu1418
 
Dm pathophysiology bkc
Dm pathophysiology  bkcDm pathophysiology  bkc
Dm pathophysiology bkc
drbalwant choure
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
Kundlik Rathod
 
screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugs
borude123
 
Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.
Raaz Eve Mishra
 

Similar to Antidiabetic screening (20)

PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF  ANTIDIABETICS.pptxPRECLINICAL SCREENING OF  ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
 
Diabetes screening
Diabetes screeningDiabetes screening
Diabetes screening
 
Preclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsPreclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugs
 
Experimental evaluation of anti-diabetics
Experimental evaluation of anti-diabeticsExperimental evaluation of anti-diabetics
Experimental evaluation of anti-diabetics
 
Models for screening of antidiabetic agents
Models for screening of antidiabetic agentsModels for screening of antidiabetic agents
Models for screening of antidiabetic agents
 
Methods for screening of hypoglycemics
Methods for screening of hypoglycemicsMethods for screening of hypoglycemics
Methods for screening of hypoglycemics
 
methodsforscreeningofhypoglycemics-180928062900 (1).pdf
methodsforscreeningofhypoglycemics-180928062900 (1).pdfmethodsforscreeningofhypoglycemics-180928062900 (1).pdf
methodsforscreeningofhypoglycemics-180928062900 (1).pdf
 
Em antidiabetic drugs
Em antidiabetic drugsEm antidiabetic drugs
Em antidiabetic drugs
 
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGSANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
 
preclinical screening methods for Antidiabetic drugs
 preclinical screening methods for Antidiabetic drugs preclinical screening methods for Antidiabetic drugs
preclinical screening methods for Antidiabetic drugs
 
Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.
 
Diabetes mellitus (DM) ...
  Diabetes  mellitus (DM)                                                    ...  Diabetes  mellitus (DM)                                                    ...
Diabetes mellitus (DM) ...
 
diabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptxdiabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptx
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
 
Screening model of antidiabetic drugs
Screening model of antidiabetic drugsScreening model of antidiabetic drugs
Screening model of antidiabetic drugs
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 
Dm pathophysiology bkc
Dm pathophysiology  bkcDm pathophysiology  bkc
Dm pathophysiology bkc
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
 
screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugs
 
Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.
 

Recently uploaded

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Antimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistanceAntimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistance
GovindRankawat1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 

Recently uploaded (20)

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Antimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistanceAntimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistance
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 

Antidiabetic screening

  • 1. SCREENING METHODS OF ANTIDIABETIC DRUGS PRESENTED BY: SHUBHA SHARMA M.SC. PHARMACOLOGY RUHS-CMS, JAIPUR
  • 2. INTRODUCTION  The pancreas is an organ composed of exocrine and endocrine cells.  Islets of langerhans, which forms the endocrine part , consist of four types of cells alpha, beta, delta and PP cells.  Glucose stimulates the beta cells to release insulin, which then promotes glucose uptake and storage.  “Diabetes mellitus is characterized by derangement in carbohydrate, protein and fat metabolism caused by the complete or relative insufficiency of insulin secretions and/ or insulin action.”
  • 3. TYPES OF DIABETES There are 2 major types of diabetes: 1) Type 1 Diabetes (associated with insulin deficiency)  Also called as Insulin-dependant diabetes mellitus (IDDM)/ juvenile onset  Type 1 diabetes is believed to be an autoimmune condition. It happens when immune system mistakenly attacks and destroys the beta cells in your pancreas that produce insulin. The damage is permanent.
  • 4. 2) Type 2 Diabetes (associated with insulin resistance)  Also called as Non Insulin-dependant Diabetes mellitus (NIDDM)  Most common form of diabetes. Usually occurs in adulthood but diagnosis is in the younger generation.  The exact cause is unknown. Contributing factors may include genetics, obesity, hyperinsulinemia and insulin resistance.  Insulin resistance may be due to the defect at receptor level or at the postreceptor level.  This means your body can’t use insulin efficiently.
  • 6. MODELS FOR IDDM (TYPE I) 1. Chemically induced diabetes  Alloxan  Streptozotocin 2. Hormones induced diabetes 3. Virus induced diabetes 4. Insulin antibodies- induced diabetes 5. Surgically induced diabetes
  • 7. MODELS FOR NIDDM (TYPE II) 1. Chemically induce d Diabetes i. Neonatal STZ model for NIDDM 2. Genetic models I. Monogenic model for NIDDM a) Yellow Mouse (The Agouty Mouse) b) Obese and Diabetic Mouse II. Polygenic model for NIDDM a) New Zealand Obese mouse (NZO) b) Japanies KK Mouse
  • 8. CHEMICALLY INDUCED DIABETES 1. Alloxan induced Diabetes:  Alloxan have capacity to produce reversible diabetes.  It is a toxic cyclic urea analogue which destroys β-cells of the islets of Langerhans in pancreas.  This compound causes severe necrosis of pancreatic β-cells .  It has been suggested that allloxan induces the production of H 2O2 and some free radicals such as O2 and OH- that produce first damage and later the death of β-cells.
  • 9. Mechanism Alloxan has two distinct pathological effects:  Alloxan is highly reactive molecule that is readily reduced to dialuric acid, Dialuric acid is then auto-oxidized back to alloxan resulting in the production of free radicals. These free radicals damage the DNA of β -cells and cause cell death.  Its ability to react with protein SH groups, especially the membrane proteins like Glucokinase on the β - cells, finally resulting in the cell necrosis..
  • 10. Procedure  Animals: Rats of Wistar or Sprague–Dawley strain(150-200 g)  Inducing agent: Alloxan (100-175 mg/kg s.c.)  Maintain rats at standard environment and laboratory chow.  All the animals , which are given alloxan, receive glucose and insulin for one week and food ad libitum.  Thereafter, single daily dose of 28 IU insulin is administered s.c.  The blood glucose level shows triphasic change, first a rise at 2Hr, followed by hypoglycemic phase at 8Hr, finally an increase at 24Hr probably due to depletion of β -cells of insulin.
  • 11. Evaluation:  Any suitable method for estimation of  Glucose level  Insulin level  Hepatic glycogen level  Compare results of standard with control group animals.
  • 12. Drawbacks  High mortality in Rats  Causes ketosis in animals due to free fatty acid generation  Diabetes induced is reversible  Some species like guinea pigs are resistant to its diabetogenic action Alloxan has been almost completely replaced by streptozotocin(STZ) because of these drawbacks
  • 13. 2. Streptozotocin-induced Diabetes  STZ [2- deoxy-2-(3-methyl-3-nitrosourea)1-D-glucopyranose]  It is a broad-spectrum antibiotic, which is produced from Streptomyces achromogens.  It is used to induce both type 1 diabetes and type 2 diabetes at dose of 1. Rat: 50-60 mg/kg i.p 2. Mice: 175-200mg/kg i.p or i.v 3. Dogs: 15mg/kg for 3 days
  • 14.  Mechanism of causing B- cell damage a) By process of methylation b) Free radical generation and c) Nitric oxide production
  • 15. Procedure  STZ induces diabetes in almost all species of animals. Diabetic dose varies with species and the optimal doses required in various species are: a) Rats(50-60mg/kg, i.p. or i.v.) b) Mice(175-200mg/kg, i.p. or i.v.) c) Dogs(15 mg/kg for 3 days)  The blood glucose level shows the same triphasic response as seen in the alloxan treated animals, with hyperglycemia at 1Hr,followed by hypoglycemia which lasts for 6 Hr, and stable hyperglycemia by 24-48Hr after STZ administration.
  • 16. Advantages  It has completely replaced Alloxan for inducing diabetes because of : 1. Greater selectivity towards B-cells 2. Lower mortality rate 3. Irreversible diabetes induction
  • 17. MODIFICATIONS  Multiple low dose of STZ also induces diabetes by causing immune mediated pancreatic insulitis in rats.  Cyclosporin-A when given with STZ enhances its diabetogenic efficacy.  STZ combined with complete Freund’s adjuvant, administered 24h prior to STZ (25mg/kg)and then repeated in the three subsequent weeks, all produces hyperglycemia.  Neither four administration of CFA nor of STZ alone result in persistent hyperglycemia.
  • 18. Hormones Induced Diabetes  Animal: Rats, Guinea pigs and Rabbits  Inducing hormone: Dexamethasone.  Eg. NIDDM form of diabetes is induced when dexamethasone,a long- acting glucocorticoid is administered at a dose of 2-5mg/kg i.p. twice a day in rats  In other animal models(like guinea pigs and rabbits), corticotrophin is used to stimulate adrenal cortex that results in hormonal imbalance causing steroidal diabetes.
  • 19. VIRUS INDUCED DIABETES  Principle: - various human viruses used for inducing diabetes include  RNA picorno virus  encephalomyocarditis [EMC-D]  coxsackie B4 [CB-4].  Renovirus  Mengo-2t
  • 20. PROCEDURE  6-8 week old mice are inoculated by 0.1 ml of 1:50 dilutions of D- variant encephalomyocarditis [EMC] through i.p.  0.1ml of above dilution contains 50 PFU [ plaque forming units] of EMC virus. (mortality due to this concentration of virus is approximately 10-20%)  A less infecting variant produces a comparable damage by eliciting autoimmune reactivity to the beta cells.  Infected animals are considered hyperglycaemic if there non fasting levels exceed by 250mg/dl  Drug samples to be screened are administered orally for a period of 6 weeks.  After 6 weeks of drug treatment, blood glucose estimation is done to determine the anti diabetic activity.
  • 21. Insuline Antibodies-induced Diabetes  Giving Bovine insulin along with CFA to guinea pigs produces anti- insulin antibodies.  Large doses and prolonged administration are accompanied by ketonemia, ketonuria, glycosuria and acidosis are fatal to animals  Lower doses produce reversible type of diabetes after a few hours.
  • 22. Surgically -induced Diabetes  Surgical removal of all or a part of pancreas.  Total removal of pancreas result in the insulin dependant type of diabetes.  Experimental animals are required to maintain isulin therapy.  Pancreatectomy with chemical agents can produce a stable form of diabetes in animlas such as cats and dogs.  The combination therapy reduces the organ damage associated with chemical induction and minimizes the interventions.
  • 23. Genetically diabetic animals The NOD Mouse  Non Obese Diabetic Mouse  These are the inbred strain of albino mice developed by Makino and coworkers in Japan.  Autoimmune destruction of β-cell in association with Insulitis and auto- antibody production.  Develop diabetes abruptly at the 100-200 days of age.  Insulin treatment required for survival.
  • 24. Genetically diabetic animals …. WBN/ KOB rat:  InbreedWistarstrain.  Decrease in number and size of islets at 12 weeks of age.  Aged male Wistar strain shows diabetic symptoms.  Impairedglucosetoleranceandglycosuriaat21week of age.
  • 25. MODELS FOR NIDDM 1. NEONATAL STZ MODEL Streptozotocin causes severe pancreatic beta cells destruction, accompanied by decrease in pancreatic insulin stores and rise in plasma insulin levels. Procedure: - • Neonatal rats of Sprague-Dawley strain are taken • Treated with STZ 80-100 mg/kg IP at birth or within 5 days of birth which leads to severe β cell destruction, deficiency in pancreatic insulin levels and rise in plasma glucose. • In contrast to adults, the β cells in neonates partially regenerate. • Following an initial spike in plasma glucose, these rats become normoglycemic by 3 weeks.
  • 26. Other chemical methods • For NIDDM in rabbits - adrenaline (0.1 mg/kg SC). • The hyperglycemia is seen at 1 hour and lasts for 4 hours. Oral hypoglycemic agents can be screened by this method. • Other chemicals are 8-hydroxy quinoline, biphenyl thio carbazine, EDTA (partially depancreatized rats), thiazides, chlorthiazide, hydrochlorthiazide, diazoxide and furosemide.
  • 27. Genetic models for NIDDM  Monogenic models of obesity and NIDDM 1. Yellow mouse (the Agouti mouse) 2.Obese and diabetic mouse 3.Tubby mouse 4.Fat mouse 5.Zucker diabetic fatty rat 6.Koletsky and JCR: LA-Corpulent rats  Polygenic models of obesity and NIDDM 1. New Zealand obese mouse 2. Japanese KK mouse 3. Nagoya – Shibata – Yasuda mouse 4. PBB/Ld mouse 5. Goto-Kakisaki rat 6. Chinese Hamster 7. South African Hamster